Dr Dipak Solanki, M.D

Professor of Medicine,
Consultant Physician.

[IDSA @IDSAInfo]

Our new Staphylococcus aureus Bacteremia consensus statements (https://t.co/rom1Wf7khr) give clinicians a roadmap for assessing the severity of infection and how a risk stratification approach can be useful for determining duration of antibiotic therapy.

https://t.co/sNnl3YlmOm

[Clinical Infectious Diseases @CIDJournal]

A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons

�� Just Accepted
https://t.co/ozHaoS7Br5

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕💥🟢 The Clash of the Titans

Ceftolozane/tazobactam 🆚 ceftazidime/avibactam: AAC

📊 Large national VHA retrospective cohort
👥 260 patients from 66 U.S. hospitals
🦠 Hospitalized adults with multidrug-resistant Pseudomonas aeruginosa pneumonia

🔍 Head-to-head: no significant difference in clinical outcomes.
⚖️ No clear winner.

🎯 Comparable outcomes — let the evidence guide the choice.

#IDXposts
https://t.co/9ApwDHWL2P

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥🔥Back online🔥🔥
IDSA/ESCMID 2026 Guidelines on Staphylococcus aureus Bacteremia: Risk Stratification, Diagnostic Evaluation, and Management of Adults and Children Part-1
#IDXposts
https://t.co/X1kOKsrVfg

[Sann @san_x_m]

For years, doctors noticed something strange about vaccines in India.

Vaccines that worked well in Europe and America worked less well in Indian children. Same vaccine, same dose, weaker protection.

Most people accepted it. One scientist in Vellore spent 30 years asking why.

Her name is Gagandeep Kang.

She trained as a doctor at Christian Medical College in Vellore, in Tamil Nadu, and then did something unusual for a physician. She went into the laboratory and stayed there.

Her subject was the gut.

Specifically, the guts of children in poor households. She studied what repeated diarrhoeal infection does to a child's intestine over the first years of life.

What she found matters enormously. Those repeated infections do not just make a child ill. They damage the lining of the gut, stunt growth, and interfere with how the body responds to oral vaccines.

That is why a vaccine developed in a clean environment abroad underperforms in a child who has had 10 infections before the age of 2. The problem was never the vaccine. It was what the child's gut had already been through.

Then she went further than diagnosis.

Rotavirus is the leading cause of severe diarrhoea in small children and it kills a very large number of them. India had access to imported rotavirus vaccines, but they were expensive and often out of reach for the families who needed them most.

Kang led the clinical trials for Rotavac, India's first indigenous rotavirus vaccine, made by an Indian company. She was also central to the work behind a second one, Rotasiil.

Both are now approved by the World Health Organisation. Rotavac went into India's national immunisation programme, which means it reaches children whose parents pay nothing for it.

In 2019 she became the first Indian woman scientist working in India to be elected a Fellow of the Royal Society, the scientific body founded in London in 1660. It took 359 years.

She has served on the World Health Organisation's global advisory committee on vaccine safety, and she now leads global health work at one of the largest health foundations in the world.

She built her career on a question most people did not think was worth asking.

Not how do we get vaccines to poor children. But why do they not work as well when they get there.

[Muthukrishnan Dhandapani @dmuthuk]

Top 10% of Indians earn 57% of national income.

The remaining 90% earn 43%.

GDP per capita of India is about $2,700.

If you set aside the top 10%, the balance 90% has an implied GDP per capita of only about $1,300. That is below the national averages of Pakistan and sub Saharan Africa. It shows how much the national average is pulled up by the top.

If you are not among the top 150 million and are part of the remaining 1.3 billion, daily life is extremely hard for a very large share of people.

Because 150 million is itself a huge number, the country looks more prosperous than it is for most citizens.

As the Indus Valley report from Blume Ventures pointed out, around 1,000 million Indians have almost no room to spend beyond very basic needs. They are not a market for discretionary goods. Public support matters a great deal for survival at that level.

As a country, we have a very long way to go.

Loving the country does not mean ignoring reality. Some people say that in every country only the top 10% thrive and the rest struggle.

That does not make India typical. India is unusual in both the depth of poverty and the concentration of income.

I mentioned that the top 10% of Indians earn about 57% of national income. In countries such as Germany, Italy, Japan, South Korea and France, household survey data put the top 10% closer to around 25% of national income. Even in the United States, survey data put that share near 30%.

Below are approximate GDP per capita figures for 10 large rich countries. The first number is the national average, meaning total income of the country divided by its whole population.

The second number is a rough figure for the bottom 90%, meaning what the average looks like if you leave out the richest tenth.

In these countries the second number stays high. In India it collapses.

United States: $89,105 and $68,800
Germany: $55,911 and $47,100
United Kingdom: $54,949 and $45,100
Canada: $53,558 and $45,800
France: $46,792 and $41,200
South Korea: $34,642 and $28,000
Japan: $33,956 and $27,900
Italy: $41,091 and $33,700
Australia: $64,547 and $52,300
Spain: $36,192 and $31,900

We not only create less income and wealth per person, and what we create is far more concentrated.

[Dr Dipak Solanki, M.D @DrDipak4]

@thewire_in Have you seen video how brutally he killed a woman in public area

[Tukaram Mundhe @Tukaram_IndIAS]

When a label lies, the consumer pays the price.

An expiry date is not just ink on a package.A nutrition label is not just information.They are promises made to the consumer.

When those promises are deliberately manipulated, it is not merely a violation of regulations, it is a breach of public trust.

Effective regulation is not about creating fear in the industry. It is about creating an ecosystem where honest businesses are protected, violations are detected, and citizens are not deceived

#TukaramMundhe #FoodSafety #Leadership #Inspairation #FDA #GenZ

https://t.co/fb7eSZZpPC

[Dr Dipak Solanki, M.D @DrDipak4]

@farman4x 110

[Congress Kerala @INCKerala]

Modi invented Insolvency and Bankruptcy Code in 2016 exactly for making money out of loan write-offs. Arun Shourie exposed this several years ago.

They'll write off 99.97% of the loan and take money from the promoter who will buy back the business cleverly using their relatives. Here gives an clear example of how it is done.

Make no mistake @narendramodi, has institutionalized corruption in this country. It took British 200 years to loot this country and he is doing it in record time.

[Rahul Gandhi @RahulGandhi]

NCLT - “नेता-कंपनी लूट ट्रिब्यूनल”

किसान 50 हज़ार न चुकाए तो ज़मीन नीलाम हो जाती है। Salaried एक EMI न भर पाएं तो घर पर बैंक के गुंडे पहुंच जाते हैं। गरीब छात्रों को तो शिक्षा तक के लिए लोन नहीं मिलता।

मगर, चुनिंदा "मित्रों" के लिए बैंक का पैसा निजी संपत्ति है - कितना भी निकालो, जो मर्ज़ी चुकाओ।

मोदी सरकार ने देश में दो व्यवस्थाएं बना रखी हैं - एक चंद अरबपतियों के लिए, दूसरी बाक़ी सबके लिए।

[Ajit Anjum @ajitanjum]

ZEE टीवी के मालिक सुभाष चंद्रा में 'सुरख़ाब के पर' लगे हैं क्या भाई?
कर्ज था 22006 करोड़ का , चुकाया 6.5 करोड़ और कर्जमुक्त मुक्त हो गए ?
यानि कुल कर्ज का सिर्फ 0.03 फ़ीसदी चुकाकर फ्री हो गए ?
इसी देश में लाख - दो लाख के बकाये पर बैंक वाले रिकवरी एजेंट भेज देते हैं . ���ुर्की का ऑर्डर ले आते हैं और लाला जी पर ऐसी मेहरबानी?
NCLT में ��ैठे लोगों ने किसके कहने पर ये किया ?

[Dr. AK 🇮🇳 @docakx]

Hydrochlorothiazide is the only blood-pressure medicine in the list classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen. This means there is sufficient evidence that it can cause cancer in humans.

It is primarily linked to squamous cell carcinoma of the skin and cancer of the lip. The main reason is phototoxicity. The drug makes the skin more sensitive to ultraviolet light from the sun. Higher cumulative doses and long-term use increase the risk, especially in people with significant sun exposure.

Important nuance: Group 1 is a hazard classification, not a guarantee that cancer will develop. For the large majority of patients, the clear benefits of controlling high blood pressure far outweigh this added risk. Particularly when simple sun-protection measures (sunscreen, hats, limiting midday sun) are followed.

⚠️Caution: Never stop any prescribed medication on your own. Always discuss this information with your doctor before making any change.

[Dr Dipak Solanki, M.D @DrDipak4]

@PMvasavada Agree

[Dr Dipak Solanki, M.D @DrDipak4]

@simplify_drugs Daptomycine

[Dr Dipak Solanki, M.D @DrDipak4]

@CJP_for_India 10

[Dr Dipak Solanki, M.D @DrDipak4]

@DrNaseemSuhail Percussion myotonia

[Akhilesh Yadav @yadavakhilesh]

‘आरक्षण सुधार’ के नाम पर ‘आरक्षण समाप्ति’ का षड्यंत्र पीडीए समाज के ख़िलाफ़ एक और गहरी साज़िश है। आरक्षण पीडीए का अधिकार है किसी की इच्छा का विषय नहीं।

भाजपा व उनके संगी-साथी समय-समय पर जिस तरह कभी ‘समीक्षा’ तो कभी ‘सुधार’ जैसे अस्पष्ट शब्दों का प्रयोग कर आरक्षण का विरोध करते हैं या कभी ‘क्रीमीलेयर’ की बात करते हैं या ‘आरक्षण त्यागने’ की सलाह देते हैं, वो सदियों से शोषित-वंचित लोगों को मिले आरक्षण के अधिकार की हक़मारी की लगातार की जा रही कोशिश के अलग-अलग मुखौटे हैं।

आरक्षण था, आरक्षण ��ै, आरक्षण रहेगा!

[Clinical Infectious Diseases @CIDJournal]

Oral Wash PCR Improves the Diagnosis of Pneumocystis Pneumonia in Immunocompromised Patients Without HIV: A Prospective Multicenter Study

🔁 Repost
🔗 https://t.co/QZvLw93Ewq

[Open Forum Infectious Diseases @OFIDJournal]

Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naïve and Pre-treated PLWH who are Virologically Suppressed, in Routine Clinical Care

✅ Just Accepted
🔗 https://t.co/lAPuRHbFWB